| 4.97 Data as of May 23 |  +0.20 / +4.19%Today’s Change | 3.68 Today|||52-Week Range 7.58 | +15.32% Year-to-Date |
| Previous close | 4.77 |
| Today’s open | 4.75 |
| Day’s range | 4.70 - 4.98 |
| Volume | 180,669 |
| Average volume (3 months) | 257,375 |
| Market cap | $257.6M |
| Dividend yield | -- |
| Earnings growth (last year) | -68.00% |
| Earnings growth (this year) | +275.00% |
| Earnings growth (next 5 years) | +14.70% |
| Revenue growth (last year) | +16.93% |
| P/E ratio | 31.1 |
| Price/Sales | 1.56 |
| Price/Book | 1.82 |
| Today’s change | Today’s % change | |
|---|---|---|
| RGLSRegulus Therapeutics... | +0.20 | +2.80% |
| RGENRepligen Corp | +0.27 | +3.28% |
| XNPTXenoport Inc | 0.00 | 0.00% |
| CNDOCoronado Biosciences... | +0.24 | +2.56% |
| Next reporting date | July 30, 2013 |
| EPS forecast (this quarter) | $0.15 |
| Annual revenue (last year) | $156.3M |
| Annual profit (last year) | $9.6M |
| Net profit margin | 6.16% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Friedhelm Blobel, PhD |
CFO, Senior Vice President & Head-Media Relations Gary S. Titus, CPA |
Corporate headquarters Foster City, California |
.
